Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tocilizumab may be a potential addition to our weapons against neuro-Behçet's disease.

× No keyword cloud information.

7 in total

1. Tocilizumab: A new anti-rheumatic drug.

Authors: Hisham S Abou-Auda; Walid Sakr
Journal: Saudi Pharm J Date: 2010-08-03 Impact factor: 4.330

Review 2. Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors: Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal: Intern Emerg Med Date: 2014-01-12 Impact factor: 3.397

Review 3. Differential diagnosis and management of Behçet syndrome.

Authors: Nicola L Ambrose; Dorian O Haskard
Journal: Nat Rev Rheumatol Date: 2012-09-25 Impact factor: 20.543

4. Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.

Authors: Luca Cantarini; Giuseppe Lopalco; Antonio Vitale; Laura Coladonato; Donato Rigante; Orso Maria Lucherini; Giovanni Lapadula; Florenzo Iannone
Journal: Clin Rheumatol Date: 2014-04-15 Impact factor: 2.980

5. Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors: Osman Köse
Journal: Patholog Res Int Date: 2012-04-03

6. Managing Behçet's disease: An update on current and emerging treatment options.

Authors: P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal: Ther Clin Risk Manag Date: 2009-05-20 Impact factor: 2.423

Review 7. Recent understanding on diagnosis and management of central nervous system vasculitis in children.

Authors: Ludovico Iannetti; Roberta Zito; Simone Bruschi; Laura Papetti; Fiorenza Ulgiati; Francesco Nicita; Francesca Del Balzo; Alberto Spalice
Journal: Clin Dev Immunol Date: 2012-09-12

7 in total